Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States.

Viruses - 7 Jan 2022

Capoferri Adam A, Shao Wei, Spindler Jon, Coffin John M, Rausch Jason W, Kearney Mary F

Abstract excerpt

COVID-19 vaccines were first administered on 15 December 2020, marking an important transition point for the spread of SARS-CoV-2 in the United States (U.S.). Prior to this point in time, the virus spread to an almost completely immunologically naïve population, whereas subsequently, vaccine-induced immune pressure and prior infections might be expected to influence viral evolution. Accordingly, we conducted a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to COVID-19 Vaccines
Share to Evolution, Molecular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Phylogeny

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 35062308
DOI: 10.3390/v14010104
PMCID: PMC8778900

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States.PMID 35062308Read ↗

Determinants of Genomic Diversity and Impact of Mutations in SARS-CoV-2.Semantic proximity Read ↗

Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global PerspectiveSemantic proximity Read ↗

A program for real-time surveillance of SARS-CoV-2 geneticsSemantic proximity Read ↗

Rapid evolution of SARS-CoV-2 challenges human defenses.Semantic proximity Read ↗

Worldwide tracing of mutations and the evolutionary dynamics of SARS-CoV-2Semantic proximity Read ↗

Analysis of SARS-CoV-2 genome evolutionary patterns.Semantic proximity Read ↗

A SARS-CoV-2 vaccine candidate would likely match all currently circulating strainsSemantic proximity Read ↗

Pandemic preparedness through genomic surveillance: Overview of mutations in SARS-CoV-2 over the course of COVID-19 outbreakSemantic proximity Read ↗

COVID-19, the first pandemic in the post-genomic era.Semantic proximity Read ↗

Evolutionary trajectory of SARS-CoV-2 genome shifts during widespread vaccination and emergence of Omicron variantSemantic proximity Read ↗

SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine StrategiesSemantic proximity Read ↗

A program for real-time surveillance of SARS-CoV-2 genetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.